ATE291922T1 - Makrolidcitrat-haltige formulierungen mit kontrollierter freisetzung - Google Patents
Makrolidcitrat-haltige formulierungen mit kontrollierter freisetzungInfo
- Publication number
- ATE291922T1 ATE291922T1 AT02256823T AT02256823T ATE291922T1 AT E291922 T1 ATE291922 T1 AT E291922T1 AT 02256823 T AT02256823 T AT 02256823T AT 02256823 T AT02256823 T AT 02256823T AT E291922 T1 ATE291922 T1 AT E291922T1
- Authority
- AT
- Austria
- Prior art keywords
- controlled release
- citrate
- release formulations
- formulations containing
- macrolide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1018DE2001 | 2001-10-01 | ||
IN1019DE2001 | 2001-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE291922T1 true ATE291922T1 (de) | 2005-04-15 |
Family
ID=26324885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02256823T ATE291922T1 (de) | 2001-10-01 | 2002-10-01 | Makrolidcitrat-haltige formulierungen mit kontrollierter freisetzung |
Country Status (9)
Country | Link |
---|---|
US (1) | US6642276B2 (de) |
EP (1) | EP1302205B1 (de) |
JP (1) | JP2003212757A (de) |
AT (1) | ATE291922T1 (de) |
BR (1) | BR0208526A (de) |
CA (1) | CA2405918A1 (de) |
DE (1) | DE60203461T2 (de) |
DK (1) | DK1302205T3 (de) |
PT (1) | PT1302205E (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US20050249786A1 (en) * | 2001-09-28 | 2005-11-10 | Solubest Ltd. | Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
US20040185097A1 (en) * | 2003-01-31 | 2004-09-23 | Glenmark Pharmaceuticals Ltd. | Controlled release modifying complex and pharmaceutical compositions thereof |
NZ543395A (en) * | 2003-05-06 | 2008-04-30 | Nirmal Mulye | Controlled release formulation of erythromycin derivatives |
AU2004249211A1 (en) | 2003-06-16 | 2004-12-29 | Andrx Pharmaceuticals, Llc | Oral extended-release composition |
WO2005004919A2 (en) * | 2003-07-02 | 2005-01-20 | Eurand, Inc. | Extended release systems for macrolide antibiotics |
EP1648415A4 (de) | 2003-07-21 | 2011-11-16 | Middlebrook Pharmaceuticals Inc | Antibiotisches produkt, seine verwendung und formulierung |
EP1648407A4 (de) | 2003-07-21 | 2011-08-31 | Middlebrook Pharmaceuticals Inc | Antibiotisches produkt, seine verwendung und formulierung |
JP2006528185A (ja) | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
US20050049209A1 (en) * | 2003-08-06 | 2005-03-03 | Chen Andrew Xian | Pharmaceutical compositions for delivering macrolides |
JP2007502296A (ja) | 2003-08-11 | 2007-02-08 | アドバンシス ファーマスーティカル コーポレイション | ロバストペレット |
AU2004264356B2 (en) | 2003-08-12 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
EP1658034A4 (de) | 2003-08-29 | 2011-06-22 | Middlebrook Pharmaceuticals Inc | Antibiotisches produkt, seine verwendung und formulierung |
WO2005027877A1 (en) | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
US20050084540A1 (en) * | 2003-10-17 | 2005-04-21 | Indranil Nandi | Taste masking antibiotic composition |
US8168228B2 (en) * | 2003-10-17 | 2012-05-01 | Sandoz Ag | Antibiotic clarithromycin micropellet compositions |
US20050101547A1 (en) * | 2003-11-06 | 2005-05-12 | Sadatrezaei Mohsen | Stabilized azithromycin composition |
EP1732518A1 (de) * | 2004-03-24 | 2006-12-20 | Lupin Ltd. | Clarithromycin-formulierung mit verlängerter freisetzung |
EP1729727B1 (de) * | 2004-04-01 | 2019-07-03 | Hadasit Medical Research Services and Development Ltd. | Verbesserte formulierungen des 6-mercaptopurins |
US8188067B2 (en) * | 2004-04-01 | 2012-05-29 | Teva Pharmaceutical Industries Ltd. | Formulations of 6-mercaptopurine |
CA2572292A1 (en) | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
JP5004236B2 (ja) * | 2005-02-09 | 2012-08-22 | キッセイ薬品工業株式会社 | 口腔内崩壊錠 |
US20070087056A1 (en) * | 2005-08-09 | 2007-04-19 | Claudia Guthmann | Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility |
US20070087055A1 (en) * | 2005-10-14 | 2007-04-19 | David Jan | Directly compressible extended release alprazolam formulation |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US20070202164A1 (en) * | 2006-02-28 | 2007-08-30 | Hutchison Medipharma Enterprises Limited | Andrographis Extract Formulations |
WO2007126039A1 (ja) * | 2006-04-28 | 2007-11-08 | Shionogi & Co., Ltd. | マクロライド系抗生物質の被覆製剤 |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
EP2030613A1 (de) * | 2007-08-17 | 2009-03-04 | Abbott GmbH & Co. KG | Herstellung von Zusammensetzungen mit hauptsächlich nichtkristallinen eingebetteten Makrolid-Antibiotika |
US20090263482A1 (en) * | 2008-04-18 | 2009-10-22 | Vered Rosenberger | Treatment of inflammatory bowel disease with 6-mercaptopurine |
CN101624412B (zh) * | 2008-07-10 | 2012-07-04 | 刘力 | 大环内酯类衍生物及其制备和用途 |
EP2283824B1 (de) | 2009-07-30 | 2017-04-19 | Special Products Line S.p.A. | Zusammensetzungen und Formulierungen, die auf quellbaren Matrizen basieren, zur verzögerten Freisetzung von schlecht löslichen Arzneimitteln, wie zum Beispiel Clarithromycin |
JP2013180961A (ja) * | 2012-02-29 | 2013-09-12 | Astellas Pharma Inc | Ws727713含有固形製剤 |
EP2671571A1 (de) | 2012-06-05 | 2013-12-11 | Sanovel Ilac Sanayi ve Ticaret A.S. | Formulierungen von Clarithromycin mit gesteuerter Freisetzung |
CN103776945A (zh) * | 2014-01-16 | 2014-05-07 | 扬子江药业集团南京海陵药业有限公司 | 罗红霉素胶囊的质量控制方法 |
WO2017066619A1 (en) | 2015-10-16 | 2017-04-20 | Teva Pharmaceutical Industries Ltd. | Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine |
CN105997929A (zh) * | 2016-06-23 | 2016-10-12 | 南京华宽信息咨询中心 | 一种罗红霉素胶囊及其制备方法 |
CN106580903B (zh) * | 2016-11-17 | 2019-12-13 | 江苏豪森药业集团有限公司 | 罗红霉素缓释药物组合物 |
CN109248155B (zh) * | 2018-09-27 | 2020-08-11 | 北京鑫开元医药科技有限公司 | 一种罗红霉素胶囊及其制备工艺 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE66143T1 (de) * | 1985-01-11 | 1991-08-15 | Abbott Lab | Feste zubereitung mit langsamer freisetzung. |
US5457111A (en) * | 1991-09-05 | 1995-10-10 | Abbott Laboratories | Macrocyclic immunomodulators |
US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
US5750510A (en) * | 1997-04-04 | 1998-05-12 | Abbott Laboratories | 3-descladinose-2,3-anhydroerythromycin derivatives |
US6551616B1 (en) * | 1997-04-11 | 2003-04-22 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
JPH10335732A (ja) * | 1997-06-02 | 1998-12-18 | Toshiba Microelectron Corp | レーザ用制御回路および制御方法 |
US6239112B1 (en) * | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
IT1303671B1 (it) * | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
SI20150A (sl) * | 1999-02-19 | 2000-08-31 | Lek, Tovarna Farmacevtskih In | Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina |
TR200000054A2 (tr) * | 2000-01-05 | 2001-08-21 | Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇ | Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları. |
-
2002
- 2002-09-30 CA CA002405918A patent/CA2405918A1/en not_active Abandoned
- 2002-09-30 US US10/261,564 patent/US6642276B2/en not_active Expired - Fee Related
- 2002-10-01 DK DK02256823T patent/DK1302205T3/da active
- 2002-10-01 DE DE60203461T patent/DE60203461T2/de not_active Expired - Lifetime
- 2002-10-01 EP EP02256823A patent/EP1302205B1/de not_active Expired - Lifetime
- 2002-10-01 JP JP2002324526A patent/JP2003212757A/ja active Pending
- 2002-10-01 BR BR0208526-7A patent/BR0208526A/pt active Search and Examination
- 2002-10-01 AT AT02256823T patent/ATE291922T1/de active
- 2002-10-01 PT PT02256823T patent/PT1302205E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
EP1302205A1 (de) | 2003-04-16 |
CA2405918A1 (en) | 2003-04-01 |
US6642276B2 (en) | 2003-11-04 |
DK1302205T3 (da) | 2005-08-08 |
US20030077325A1 (en) | 2003-04-24 |
DE60203461T2 (de) | 2006-02-09 |
JP2003212757A (ja) | 2003-07-30 |
PT1302205E (pt) | 2005-06-30 |
EP1302205B1 (de) | 2005-03-30 |
DE60203461D1 (de) | 2005-05-04 |
BR0208526A (pt) | 2004-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE291922T1 (de) | Makrolidcitrat-haltige formulierungen mit kontrollierter freisetzung | |
AU2002357012A1 (en) | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof | |
HUP0101237A1 (hu) | Elnyújtott kioldódású gyógyszerkészítmények | |
NO20042565L (no) | Orale farmasoytiske produkter inneholdende 17 beta-ostradiol-3-lavere alkanoat, fremgangsmater for administrering av disse og fremgangsmater for fremstilling derav | |
LTC1345910I2 (lt) | Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas | |
ATE317260T1 (de) | Pharmazeutische formulierungen mit platinderivaten | |
DE60100186D1 (de) | Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung | |
NO996433L (no) | Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav | |
AU2002239282A1 (en) | Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof | |
DE69936002D1 (de) | Angepasster löffel zur oralen medikamenten-verabreichung | |
WO2003002136A3 (en) | Stable formulation of modified glp-1 | |
HUP0201877A2 (hu) | Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák | |
EE05400B1 (et) | Prasoolderivaadid, neid v?i nende farmatseutiliselt vastuv?etavaid sooli, solvaate v?i derivaate sisaldavad farmatseutilised kompositsioonid, nende kasutamine ning meetodid nende valmistamiseks | |
NO20040268L (no) | Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen | |
IL159217A0 (en) | An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine | |
DE60131760D1 (de) | Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform | |
ATA59499A (de) | Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung | |
DE60020501D1 (de) | Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe | |
MXPA03002569A (es) | Formulaciones de liberacion controlada para administracion oral. | |
AU2001272314A1 (en) | Oral formulations for localized colonic release and the method of preparation thereof | |
HUP0400317A3 (en) | Beta-carboline derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
FR2793688B1 (fr) | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques | |
HUP0401369A3 (en) | Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof | |
ATE409474T1 (de) | Tryptamin-derivative und analoge verbindungen, und pharmazeutische formulationen daraus | |
DE60316714D1 (de) | Pharmazeutische formulierung enthaltend olanzapin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1302205 Country of ref document: EP |